Select a state ----
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Patient Home
Professional Home
Newsletters
Feedback Survey
Search:
Medline
CancerConsultants.com
Both
Main Menu
Home
Conference Coverage
Current Topics in Oncology
Cancer News
Disease Centers
Physician Resources
About Us
Quick Links
Information by Disease
All
Acute Leukemia
Bladder Cancer
Bone Cancer
Breast Cancer
Cervical Cancer
Chronic Leukemia
CNS / Brain Cancer
Colon Cancer
Gastric Cancer
Head and Neck Cancers
Immune Thrombocytopenic Purpura
Liver
Lung Cancer
Lymphoma
Myelodysplastic Syndrome
Melanoma
Mesothelioma
Multiple Myeloma
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Renal Cancer
Cancer News
Select Cancer Type
Anal Cancer
Anemia
Bladder Cancer
Brain and CNS Cancers
Breast Cancer
CAM
Carcinoid Tumors
Cervical Cancer
CINV
Colon Cancer
Esophageal Cancer
Gastric Cancer
General
Head and Neck Cancers
HIV Cancers
Hodgkin's Lymphoma
Leukemia
Liver
Lung Cancer
Melanoma
Mesothelioma
Mucositis
Multiple Myeloma
Myelodysplastic Syndrome
Neuroblastoma
Neutropenia
Non-Hodgkin's Lymphoma
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Renal Cancer
Sarcoma
Skin Cancer
Stem Cell Transplant
Supportive Care
Testicular Cancer
Thyroid Cancer
Uterine Cancer
Conference Coverage
Select Conference
2007 Conference Coverage
2006 Conference Coverage
2005 Conference Coverage
2004 Conference Coverage
2003 Conference Coverage
2002 Conference Coverage
2001 Conference Coverage
Oncology Stocks
Mucositis News
Latest Mucositis News
Chlorhexidine or Oral Cooling Decrease Chemotherapy-induced Mucositis
(3/31/2008)
Kepivance® May Decrease Oral Mucositis Following High-Dose Chemotherapy
(1/8/2007)
Kepivance® Decreases Oral Mucositis in Patients with Metastatic Colorectal Cancer.
(11/27/2006)
Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation Without Impact on Acute GVHD
(11/9/2006)
Daily Low Power Laser Therapy May Prevent Oral Mucositis in Stem Cell Transplant Patients
(10/25/2006)
More Mucositis News »
Newsletters
Register in our member center today to receive a monthly newsletter with clinical news updates.
Learn More »
More on Mucositis
Review the latest current topics and conference coverage on Mucositis written by thought leaders.
Learn More »
Practice Resources
Learn how to have our news directly fed to your website.
Learn More »
Additional Resources
Anemia Center
Biological Therapy
CAM
CINV Center
Genomics
Mucositis Center
Neutropenia Center
Pain
Radiation Therapy
SCT
Supportive Care Main Center
Information by Cancer Type
Acute Leukemia
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Leukemia
Colon Cancer
Gastric Cancer
Head and Neck Cancers
Liver Cancer
Lung Cancer
Lymphoma
Myelodysplastic Syndrome
Melanoma
Mesothelioma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Renal Cancer
Sarcoma
SCLC
© 1998-2007
Cancer
Consultants.com
All Rights Reserved.